Poster
21 October 2024 Blood coagulation monitoring using refractive index
Author Affiliations +
Proceedings Volume 13186, SPIE Translational Biophotonics + Additive Manufacturing for Photonics 2024; 131861P (2024) https://doi.org/10.1117/12.3038856
Event: SPIE Translational Biophotonics + Additive Manufacturing for Photonics, 2024, Houston, Texas, United States
Conference Poster
Abstract
Prothrombin, or factor II, is vital in blood coagulation, transforming into active thrombin. The prothrombin time test (PTT) measures blood clotting time, crucial for heart disease patients on anticoagulants. Our study introduces a novel approach using refractive index to measure prothrombin time, validated through experimental outcomes. This method leverages light refraction principles, offering rapid results, simplicity, and point-of-care potential. Testing with clinical samples showed strong correlation with traditional PTT methods. Developing a point-of-care device for prothrombin time measurement promises to enhance patient care by enabling real-time monitoring of clotting efficiency, allowing timely adjustments to anticoagulant therapy, thus reducing risks of bleeding or thrombosis. The simplicity and accessibility of this method can revolutionize anticoagulant management, especially in resource-limited settings.
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
John Forshay, Luis Trabucco, and Jing Yong Ye "Blood coagulation monitoring using refractive index", Proc. SPIE 13186, SPIE Translational Biophotonics + Additive Manufacturing for Photonics 2024, 131861P (21 October 2024); https://doi.org/10.1117/12.3038856
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Blood

Refractive index

Point-of-care devices

Time metrology

Cardiovascular disorders

Heart

Refraction

Back to Top